Ramlinga Raju

ED Asks Gland Pharma to Transfer B. Ramlinga Raju's Shares to Escrow Account

Srinivas Sadhu, MD and CEO of Gland Pharma, told reporters during a virtual press conference that they are following the directions of the ED. He clarified that these shares are not part of the IPO.